Researchers are excited about the medication , a innovative dual agonist showing significant results in initial trials for weight loss . It acts by impacting both hormones : GLP-1 and GIP, these, when https://majazaxs949697.blogaritma.com/38710893/the-new-prospect-for-weight-management